Cover Image
Market Research Report

In Vitro Diagnostics - Global Market Outlook (2018-2027)

Published by Stratistics Market Research Consulting Product code 932651
Published Content info 187 Pages
Delivery time: 2-3 business days
Price
Back to Top
In Vitro Diagnostics - Global Market Outlook (2018-2027)
Published: March 1, 2020 Content info: 187 Pages
Description

According to Stratistics MRC, the Global In Vitro Diagnostics Market is accounted for $87.93 billion in 2018 and is expected to reach $164.40 billion by 2027 growing at a CAGR of 7.2% during the forecast period. Increasing adoption of fully automated instruments in labs, rising awareness on personalized medicine and consequent growth of chronic diseases are the major factors driving the market growth. However, adverse reimbursement scenario is restraining the market growth.

In Vitro Diagnostics (IVD) consists of medical devices and consumables that are utilized to detect any kind of infection and diseases by taking the specimen from the human body to cure diseases or its sequelae and perform in vitro tests on various biological samples. These products can be instruments, reagents, or any system used for the diagnosis of diseases. They are used for the diagnosis of various medical conditions, such as diabetes and cancer.

Based on end user, the point-of-care testing segment is likely to have a huge demand due rising requirements of these testing's as it includes biosensors, pregnancy kits and glucose meters to ensure quick and accurate results. By geography, North America is going to have a lucrative growth during the forecast period due to awareness among people regarding availability of innovative products and upsurge of strong prominent business players will lead to market growth.

Some of the key players profiled in the In Vitro Diagnostics Market include Abbott Laboratories Inc, Agilent Technologies, Becton Dickinson and Company, Biomerieux Sa, Bio-Rad Laboratories Inc, Cepheid, Danaher Corporation, Diasorin, Johnson & Johnson, Leica Biosystems Nussloch GmbH, Qiagen, Roche Diagnostics, Siemens AG, Sysmex Corporation and Thermo Fisher Scientific.

Usability's Covered:

  • Reusable IVD Devices
  • Disposable IVD Devices

Products Covered:

  • Data Management Software
  • Reagents & Kits
  • Services
  • Instruments

Technologies Covered:

  • Blood Testing
  • Coagulation and Hemostasis
  • Hematology
  • Immunohematology
  • Microbiology
  • Tissue Diagnostics
  • Urinalysis
  • Clinical Chemistry
  • Molecular Diagnostics
  • Immunoassay/Immunochemistry

Applications Covered:

  • Autoimmune Diseases
  • Cardiology
  • Diabetes
  • Drug Testing/Pharmacogenomics
  • Endocrinology
  • Gastrointestinal Diseases
  • HIV/Aids
  • Infectious Diseases
  • Nephrology
  • Non Infectious Diseases
  • Oncology

End Users Covered:

  • Academic Institutes
  • Home Care
  • Hospitals
  • Patient Self-Testing
  • Point-Of-Care Testing
  • Laboratories

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis, etc.
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking

Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global In Vitro Diagnostics Market, By Usability

  • 5.1 Introduction
  • 5.2 Reusable IVD Devices
  • 5.3 Disposable IVD Devices

6 Global In Vitro Diagnostics Market, By Product

  • 6.1 Introduction
  • 6.2 Data Management Software
  • 6.3 Reagents & Kits
  • 6.4 Services
  • 6.5 Instruments
    • 6.5.1 Semi-Automated Instruments
    • 6.5.2 Fully Automated Instruments

7 Global In Vitro Diagnostics Market, By Technology

  • 7.1 Introduction
  • 7.2 Blood Testing
  • 7.3 Coagulation and Hemostasis
  • 7.4 Hematology
  • 7.5 Immunohematology
  • 7.6 Microbiology
  • 7.7 Tissue Diagnostics
  • 7.8 Urinalysis
  • 7.9 Clinical Chemistry
    • 7.9.1 Basic Metabolic Panel
    • 7.9.2 Electrolyte Panel
    • 7.9.3 Lipid Profile
    • 7.9.4 Liver Panel
    • 7.9.5 Renal Profile
    • 7.9.6 Specialty Chemical Tests
    • 7.9.7 Thyroid Function Panel
  • 7.10 Molecular Diagnostics
    • 7.10.1 Dna Sequencing & Next-Generation Sequencing
    • 7.10.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 7.10.3 Microarray
    • 7.10.4 Polymerase Chain Reaction (PCR)
    • 7.10.5 Hybridization
      • 7.10.5.1 In-Situ Hybridization
      • 7.10.5.2 Fluorescence In-Situ Hybridization
  • 7.11 Immunoassay/Immunochemistry
    • 7.11.1 Enzyme-Linked Immunospot Assays
    • 7.11.2 Radioimmunoassay
    • 7.11.3 Rapid Test
    • 7.11.4 Western Blotting
    • 7.11.5 Enzyme-Linked Immunosorbent Assay
      • 7.11.5.1 Chemiluminescence Immunoassays
      • 7.11.5.2 Colorimetric Immunoassays
      • 7.11.5.3 Fluorescence Immunoassays

8 Global In Vitro Diagnostics Market, By Application

  • 8.1 Introduction
  • 8.2 Autoimmune Diseases
  • 8.3 Cardiology
  • 8.4 Diabetes
  • 8.5 Drug Testing/Pharmacogenomics
  • 8.6 Endocrinology
  • 8.7 Gastrointestinal Diseases
  • 8.8 HIV/Aids
  • 8.9 Infectious Diseases
  • 8.10 Nephrology
  • 8.11 Non Infectious Diseases
  • 8.12 Oncology

9 Global In Vitro Diagnostics Market, By End User

  • 9.1 Introduction
  • 9.2 Academic Institutes
  • 9.3 Home Care
  • 9.4 Hospitals
  • 9.5 Patient Self-Testing
  • 9.6 Point-Of-Care Testing
  • 9.7 Laboratories
    • 9.7.1 Large/Reference Laboratories
    • 9.7.2 Medium-Sized Laboratories
    • 9.7.3 Small Laboratories

10 Global In Vitro Diagnostics Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Abbott Laboratories Inc
  • 12.2 Agilent Technologies
  • 12.3 Becton Dickinson and Company
  • 12.4 Biomerieux Sa
  • 12.5 Bio-Rad Laboratories Inc
  • 12.6 Cepheid
  • 12.7 Danaher Corporation
  • 12.8 Diasorin
  • 12.9 Johnson & Johnson
  • 12.10 Leica Biosystems Nussloch GmbH
  • 12.11 Qiagen
  • 12.12 Roche Diagnostics
  • 12.13 Siemens AG
  • 12.14 Sysmex Corporation
  • 12.15 Thermo Fisher Scientific

List of Tables

  • Table 1 Global In Vitro Diagnostics Market Outlook, By Region (2017-2027) ($MN)
  • Table 2 Global In Vitro Diagnostics Market Outlook, By Usability (2017-2027) ($MN)
  • Table 3 Global In Vitro Diagnostics Market Outlook, By Reusable IVD Devices (2017-2027) ($MN)
  • Table 4 Global In Vitro Diagnostics Market Outlook, By Disposable IVD Devices (2017-2027) ($MN)
  • Table 5 Global In Vitro Diagnostics Market Outlook, By Product (2017-2027) ($MN)
  • Table 6 Global In Vitro Diagnostics Market Outlook, By Data Management Software (2017-2027) ($MN)
  • Table 7 Global In Vitro Diagnostics Market Outlook, By Reagents & Kits (2017-2027) ($MN)
  • Table 8 Global In Vitro Diagnostics Market Outlook, By Services (2017-2027) ($MN)
  • Table 9 Global In Vitro Diagnostics Market Outlook, By Instruments (2017-2027) ($MN)
  • Table 10 Global In Vitro Diagnostics Market Outlook, By Semi-Automated Instruments (2017-2027) ($MN)
  • Table 11 Global In Vitro Diagnostics Market Outlook, By Fully Automated Instruments (2017-2027) ($MN)
  • Table 12 Global In Vitro Diagnostics Market Outlook, By Technology (2017-2027) ($MN)
  • Table 13 Global In Vitro Diagnostics Market Outlook, By Blood Testing (2017-2027) ($MN)
  • Table 14 Global In Vitro Diagnostics Market Outlook, By Coagulation and Hemostasis (2017-2027) ($MN)
  • Table 15 Global In Vitro Diagnostics Market Outlook, By Hematology (2017-2027) ($MN)
  • Table 16 Global In Vitro Diagnostics Market Outlook, By Immunohematology (2017-2027) ($MN)
  • Table 17 Global In Vitro Diagnostics Market Outlook, By Microbiology (2017-2027) ($MN)
  • Table 18 Global In Vitro Diagnostics Market Outlook, By Tissue Diagnostics (2017-2027) ($MN)
  • Table 19 Global In Vitro Diagnostics Market Outlook, By Urinalysis (2017-2027) ($MN)
  • Table 20 Global In Vitro Diagnostics Market Outlook, By Clinical Chemistry (2017-2027) ($MN)
  • Table 21 Global In Vitro Diagnostics Market Outlook, By Basic Metabolic Panel (2017-2027) ($MN)
  • Table 22 Global In Vitro Diagnostics Market Outlook, By Electrolyte Panel (2017-2027) ($MN)
  • Table 23 Global In Vitro Diagnostics Market Outlook, By Lipid Profile (2017-2027) ($MN)
  • Table 24 Global In Vitro Diagnostics Market Outlook, By Liver Panel (2017-2027) ($MN)
  • Table 25 Global In Vitro Diagnostics Market Outlook, By Renal Profile (2017-2027) ($MN)
  • Table 26 Global In Vitro Diagnostics Market Outlook, By Specialty Chemical Tests (2017-2027) ($MN)
  • Table 27 Global In Vitro Diagnostics Market Outlook, By Thyroid Function Panel (2017-2027) ($MN)
  • Table 28 Global In Vitro Diagnostics Market Outlook, By Molecular Diagnostics (2017-2027) ($MN)
  • Table 29 Global In Vitro Diagnostics Market Outlook, By Dna Sequencing & Next-Generation Sequencing (2017-2027) ($MN)
  • Table 30 Global In Vitro Diagnostics Market Outlook, By Isothermal Nucleic Acid Amplification Technology (INAAT) (2017-2027) ($MN)
  • Table 31 Global In Vitro Diagnostics Market Outlook, By Microarray (2017-2027) ($MN)
  • Table 32 Global In Vitro Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2017-2027) ($MN)
  • Table 33 Global In Vitro Diagnostics Market Outlook, By Hybridization (2017-2027) ($MN)
  • Table 34 Global In Vitro Diagnostics Market Outlook, By Immunoassay/Immunochemistry (2017-2027) ($MN)
  • Table 35 Global In Vitro Diagnostics Market Outlook, By Enzyme-Linked Immunospot Assays (2017-2027) ($MN)
  • Table 36 Global In Vitro Diagnostics Market Outlook, By Radioimmunoassay (2017-2027) ($MN)
  • Table 37 Global In Vitro Diagnostics Market Outlook, By Rapid Test (2017-2027) ($MN)
  • Table 38 Global In Vitro Diagnostics Market Outlook, By Western Blotting (2017-2027) ($MN)
  • Table 39 Global In Vitro Diagnostics Market Outlook, By Enzyme-Linked Immunosorbent Assay (2017-2027) ($MN)
  • Table 40 Global In Vitro Diagnostics Market Outlook, By Application (2017-2027) ($MN)
  • Table 41 Global In Vitro Diagnostics Market Outlook, By Autoimmune Diseases (2017-2027) ($MN)
  • Table 42 Global In Vitro Diagnostics Market Outlook, By Cardiology (2017-2027) ($MN)
  • Table 43 Global In Vitro Diagnostics Market Outlook, By Diabetes (2017-2027) ($MN)
  • Table 44 Global In Vitro Diagnostics Market Outlook, By Drug Testing/Pharmacogenomics (2017-2027) ($MN)
  • Table 45 Global In Vitro Diagnostics Market Outlook, By Endocrinology (2017-2027) ($MN)
  • Table 46 Global In Vitro Diagnostics Market Outlook, By Gastrointestinal Diseases (2017-2027) ($MN)
  • Table 47 Global In Vitro Diagnostics Market Outlook, By HIV/Aids (2017-2027) ($MN)
  • Table 48 Global In Vitro Diagnostics Market Outlook, By Infectious Diseases (2017-2027) ($MN)
  • Table 49 Global In Vitro Diagnostics Market Outlook, By Nephrology (2017-2027) ($MN)
  • Table 50 Global In Vitro Diagnostics Market Outlook, By Non Infectious Diseases (2017-2027) ($MN)
  • Table 51 Global In Vitro Diagnostics Market Outlook, By Oncology (2017-2027) ($MN)
  • Table 52 Global In Vitro Diagnostics Market Outlook, By End User (2017-2027) ($MN)
  • Table 53 Global In Vitro Diagnostics Market Outlook, By Academic Institutes (2017-2027) ($MN)
  • Table 54 Global In Vitro Diagnostics Market Outlook, By Home Care (2017-2027) ($MN)
  • Table 55 Global In Vitro Diagnostics Market Outlook, By Hospitals (2017-2027) ($MN)
  • Table 56 Global In Vitro Diagnostics Market Outlook, By Patient Self-Testing (2017-2027) ($MN)
  • Table 57 Global In Vitro Diagnostics Market Outlook, By Point-Of-Care Testing (2017-2027) ($MN)
  • Table 58 Global In Vitro Diagnostics Market Outlook, By Laboratories (2017-2027) ($MN)
  • Table 59 Global In Vitro Diagnostics Market Outlook, By Large/Reference Laboratories (2017-2027) ($MN)
  • Table 60 Global In Vitro Diagnostics Market Outlook, By Medium-Sized Laboratories (2017-2027) ($MN)
  • Table 61 Global In Vitro Diagnostics Market Outlook, By Small Laboratories (2017-2027) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

Back to Top